Clausenamide

Clausenamide
Clinical data
Drug classSerotonin 5-HT2A receptor agonist; Psychoplastogen
ATC code
  • None
Identifiers
  • 3-hydroxy-5-[hydroxy(phenyl)methyl]-1-methyl-4-phenylpyrrolidin-2-one
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H19NO3
Molar mass297.354 g·mol−1
3D model (JSmol)
  • CN1C(C(C(C1=O)O)C2=CC=CC=C2)C(C3=CC=CC=C3)O
  • InChI=1S/C18H19NO3/c1-19-15(16(20)13-10-6-3-7-11-13)14(17(21)18(19)22)12-8-4-2-5-9-12/h2-11,14-17,20-21H,1H3
  • Key:WGYGSZOQGYRGIP-UHFFFAOYSA-N

Clausenamide is an alkaloid found in Clausena lansium (wampee), an evergreen tree native to Southeast Asia and southern China. The compound has multiple chiral centers and many possible enantiomers or stereoisomers. Some of its isomers, especially (–)-cis-clausenamide, show psychoplastogenic effects that may be due to serotonin 5-HT2A receptor partial agonism. In a BRET assay, (–)-cis-clausenamide showed modest potency and efficacy as a serotonin 5-HT2A receptor partial agonist (EC50Tooltip half-maximal effective concentration = 490 nM; EmaxTooltip maximal efficacy = 28.4%). A number of other biological activities of clausenamide have also been described, and the compound has potential medical applications. Clausenamide was first isolated and described in the scientific literature by 1987. The psychoplastogenic activity of clausenamide was described by David E. Olson and colleagues in 2026.

See also